Recent Articles from Business Wire

Farmland Partners Inc. (NYSE: FPI) (the “Company” or “FPI”) today announced that its Board of Directors has declared a one-time dividend of $0.20 per share of common stock and Class A Common OP Unit, payable in cash on January 7, 2026 to shareholders of record on December 23, 2025.

Zoetis Inc. (NYSE: ZTS) (the “Company” or “Zoetis”) today announced that, subject to market conditions, it intends to offer $1.75 billion aggregate principal amount of convertible senior notes due 2029 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Zoetis also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $250 million aggregate principal amount of Notes.

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that Natera voluntarily dismissed its appeal (and NeoGenomics thus dismissed its cross-appeal) of the North Carolina District Court’s August 2025 ruling. The dismissal will leave in place the ruling in NeoGenomics’ favor.

C1 Fund Inc. (NYSE: CFND) (the “Fund”), a publicly traded closed-end investment company providing public-market investors with exposure to late-stage digital-asset services and technology companies, today announced that it has acquired a position in Consensys, a leading global blockchain software company and foundational contributor to the Ethereum ecosystem.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced positive topline results from the global pivotal Phase 3 RINGSIDE trial of varegacestat, an investigational, oral, once-daily gamma secretase inhibitor (GSI), in patients with progressing desmoid tumors.

Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology, from TPG, a leading global alternative asset management firm.

Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) and MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) (CSE: MTLC) (OTCQX: MTLNF) are pleased to announce that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of MTL (the “MTL Shares”) and will settle all debt and debt-like instruments owed by MTL, in a transaction valued at approximately $125 million on a fully-diluted equity basis (the “Transaction”) and approximately $179 million on an enterprise value (“TEV”) basis. Under the terms of the Arrangement Agreement, each shareholder of MTL (an “MTL Shareholder”) will receive fixed consideration for each MTL Share equal to: (i) 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”), and (ii) $0.144 in cash.

Companion Spine, the French-American specialist in surgeon innovated spine implant surgery, announced that the U.S. Food and Drug Administration (the “FDA”) has approved the DIAM™ Spinal Stabilization System (P240043). DIAM™ Spinal Stabilization System is the first posterior motion-preserving device approved in the U.S. for the treatment of moderate to severe primary low back pain secondary to DDD at a single lumbar level (L2–L5) in patients who remain symptomatic after at least six months of non-operative care.

Attivare Therapeutics, Inc. has announced the receipt of a $6.6 million grant from the Gates Foundation, supporting the advancement of a next-generation, long-lasting malaria vaccine, powered by the proprietary ATTimmune bioscaffold platform. This project is focused on providing an affordable, robust, and easily deployable solution for malaria in low- and middle-income countries, where challenges such as limited cold-chain infrastructure often impede vaccine outreach and coverage.

LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug Administration (FDA) has approved LEROCHOLTM (lerodalcibep-liga) injection for subcutaneous use as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH).

Aviceda Therapeutics (“the Company” or “Aviceda”), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b study evaluating AVD-104 in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Virgin Galactic (NYSE: SPCE), a leader in commercial spaceflight and advanced aerospace technology, today announced a new collaboration with Lawrence Livermore National Laboratory (“LLNL”), a research and development institution operated for the U.S. Department of Energy. The collaboration will assess potential for utilizing LLNL sensor systems aboard Virgin Galactic launch vehicles in the future, with the aim of gathering critical data and accelerating the development of next-generation image-capture capabilities aboard high-altitude, long-endurance, heavy-lift (“HALE-Heavy”) aircraft.

ARDRI, a technology-forward Non-QM and Business Purpose mortgage lender, is proud to announce the appointment of Wesley Olison as Vice President of Wholesale Production. With more than 20 years of proven mortgage and finance leadership experience, Wesley joins ARDRI at a pivotal moment in the company’s expansion, bringing a powerful blend of strategic vision, operational insight, and results-driven leadership.

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod brand of products, has announced the expansion of its U.S. Pod recycling program, which is now available to all U.S. customers.

Pebblebrook Hotel Trust (NYSE: PEB) (the “Company”) today announced that its Board of Trustees has authorized, and the Company has declared, a quarterly cash dividend of $0.01 per common share of beneficial interest, to be paid on January 15, 2026, to shareholders of record as of December 31, 2025 (the “Record Date”).

For the second year in a row, IDC, a global analyst firm, named ABBYY a Leader in its IDC MarketScape: Worldwide Intelligent Document Processing Software 2025-2026 Vendor Assessment1. We believe the recognition reinforces ABBYY’s strategic leadership in the market and highlights its Document AI platform’s competitive strengths: proprietary, purpose-built models for document understanding, end-to-end process intelligence integration, and enterprise-ready deployment and compliance.

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMRs”) IN COMMON STOCK OF PAR VALUE $0.0001 EACH IN THE COMPANY (“Shares”)

On Dec. 14, 2025, the board of directors of ALLETE, Inc. (NYSE:ALE) (the Company) declared a “stub period” dividend, subject to the consummation of the merger, in an amount equal to $0.008 per share of Company common stock (which reflects the most recent regular quarterly dividend rate of $0.73 per share, divided by 91 days) multiplied by the number of days from and including August 16, 2025, the day after the record date for the most recent regular quarterly common stock dividend, to and including the closing date of the Company’s previously announced acquisition by Canada Pension Plan Investment Board and Global Infrastructure Partners.

SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets.

Knife River Corporation (NYSE: KNF) announced today that it has acquired the assets of Texcrete Operations LLC and TexAgg LLC (collectively “Texcrete”), supporting the company’s growth efforts in the Texas Triangle.

AIDS Healthcare Foundation (AHF) has launched two new national billboard and outdoor advertising campaigns. The first, “50 Countries – 2.7 Million in Care,” celebrates a historic AHF milestone: reaching operations in 50 countries worldwide, now with the recent addition of Bangladesh, an extraordinary achievement since the organization first launched its global programs in 2002 in South Africa and Uganda.

Income Laboratory, Inc. (Income Lab), the award-winning provider of dynamic, tax-smart retirement planning software, today announced a partnership with Cetera Financial Group ("Cetera"), the premier financial advisor Wealth Hub. Through this partnership, Income Lab’s modern, dynamic retirement income and planning tools, empowering advisors to deliver smarter retirement planning at scale, will be offered to approximately 12,000 financial advisors and institutions in the Cetera network.

MardiLyn Saathoff, General Counsel for NW Natural Holding Company (NYSE: NWN) (NW Natural Holdings), announced her intent to retire on April 1, 2026, after nearly 18 years of outstanding service to the company. The Board of Directors has appointed Megan H. Berge to succeed Saathoff as SVP and General Counsel, as well as Chief Compliance Officer and Corporate Secretary, effective January 1, 2026.

Innovative Industrial Properties, Inc. (NYSE: IIPR) (“IIP” or the “Company”) announced today that its board of directors has declared a fourth quarter 2025 dividend of $1.90 per share of common stock, representing an annualized dividend of $7.60 per common share. Since its inception in 2016, the Company has paid $1.1 billion in common stock dividends to its shareholders.

Strada, the media collaboration start-up co-founded by brothers Michael Cioni & Peter Cioni, today announced a significant investment from Other World Computing (OWC), the world leader in high performance storage, memory, connectivity, software, and accessories for media & entertainment customers. This investment marks a key milestone in Strada’s current fundraising program, further accelerating the Company’s product roadmap.

Despite mixed economic news throughout 2025, Forbright Bank Growth Savings customers report a high level of confidence in their money management skills and habits compared to the general population, according to results announced today from Forbright Bank’s 2025 Savings Survey. The survey of 1,317 respondents was designed to better understand how high-yield savings account holders view their financial health, especially during a time of economic uncertainty. The results may offer valuable insights for consumers, policymakers, and banking professionals across the country.

Experian Health today unveiled its predictions for the healthcare industry, a year that will be significantly shaped by new regulations, mounting financial pressures, and the shift from AI awareness to adoption. As the revenue cycle grows increasingly complex, healthcare organizations must look to harness technology to enhance human expertise in 2026.

Dole plc (NYSE: DOLE) (“Dole” or the “Company”) has today announced that certain of its subsidiaries have entered into several agreements that when completed will result in the sale of Dole’s port and port operations in Guayaquil, Ecuador to Terminal Investment Limited Holding S.A., (the “Buyer”).

Universal Synaptics Corporation (USC), the global leader in detecting and isolating elusive electrical intermittent faults that cause No Fault Found (NFF) test results, announced today that it has entered into a strategic agreement with GGAS Aviation Services (GGAS) in the Kingdom of Saudi Arabia to establish an accredited educational program for advanced Non-Destructive Testing (NDT).

Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report.

The OpenFold Consortium, a leading open-science initiative developing AI foundation models for biomolecular structure prediction, today announced that Dr. Jan Domanski has joined the consortium as senior science lead. In this role, Dr. Domanski will spearhead scientific innovation, engineering excellence, and ecosystem growth as OpenFold advances its mission to democratize access to high-performance AI models for structural biology and drug discovery. He will work closely with Dr. Jennifer Wei, OpenFold’s senior technical lead, and a global network of academic and industry contributors to build an open, modular software stack that links state-of-the-art AI models with rich experimental and simulation data to improve model generalization and robustness for drug discovery.

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with Cherry Biotech, a French company specialising in organ-on-chip and organoid technologies for biomedical research.

Palantir Technologies Inc. (NASDAQ: PLTR) announces a three-year renewal of its contract with the DGSI, France's domestic intelligence agency, extending a partnership that has been ongoing for nearly a decade. This agreement relates to the supply of Palantir’s proprietary software platform, as well as the integration, support, and assistance services that are necessary for the software’s deployment and operational use.

NOT FOR UK USE – NOT INTENDED FOR UK MEDIA

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that in collaboration with Professor Toshiaki Kamachi and colleagues from the School of Life Science and Technology at Institute of Science Tokyo (Science Tokyo) they have achieved the world’s first mechanism for elucidating the combined use of negative ions to enhance the oxidative action of ozone. In their joint study, they discovered that dissolving negative ions in the moisture surrounding viruses and other microorganisms lowers the pH due to nitrate-containing components derived from the negative ions, which in turn enhances the oxidative action of ozone in the moisture, enabling a strong reduction of viruses and bacteria even at low ozone concentrations. Mitsubishi Electric confirmed the reduction of bacteria and odors in low ozone concentrations of 50 parts per billion (ppb) in addition to specific viruses reported previously. Buildings are becoming more airtight and better insulated, raising concerns about inadequate indoor ventilation and unhygienic conditions. Ozone’s oxidative action has traditionally been used to maintain indoor hygiene, but ozone alone has faced challenges in terms of the durability and stability of its sanitizing effects. It is also known that ozone’s reduction of viruses and bacteria increases when used with negative ions and varies with pH. However, the specific chemical species of the negative ions and their pH-controlling effects had not been clarified.

American International Group, Inc. (NYSE: AIG) today announced that Scott Leney has been appointed Regional President, AIG Asia Pacific. Mr. Leney will lead AIG’s businesses in Australia, New Zealand, Singapore, Indonesia, Malaysia, Thailand, South Korea, Hong Kong, Taiwan, Vietnam, and the Philippines.

The recent easing of discount rate regulations by South Korea’s financial authorities will alleviate pressure on the solvency position of the country’s non-life insurers, according to a new AM Best commentary.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the company will host a conference call and webcast on Monday, December 15, 2025 at 8:30 am ET to disclose the topline results from the global pivotal Phase 3 RINGSIDE trial of varegacestat, an investigational, oral, once-daily gamma secretase inhibitor, in patients with progressing desmoid tumors.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Contango ORE, Inc. (NYSE American: CTGO) and Dolly Varden Silver Corporation is fair to Contango shareholders. Upon completion of the proposed transaction, Contango shareholders will own approximately 50% of the combined company.

A Los Angeles Superior Court jury on Friday delivered a $40 million verdict against Johnson & Johnson.

Scholar Rock (NASDAQ: SRRK; the “Company”), today announced that the company granted inducement equity awards covering an aggregate of 7,800 shares of its common stock to two newly hired employees, consisting of inducement stock options to purchase an aggregate of 4,457 shares of common stock and inducement restricted stock units, covering an aggregate of 3,343 shares of its common stock.

NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas Südhof, a Nobel Prize-winning neuroscientist and one of the world’s leading Alzheimer’s disease researchers, has been named Scientific Co-founder of the company and joined its Scientific Advisory Board. This follows the announcement that world-recognized neurologist Prof. Olivier Rascol, a co-creator of the current gold standard for measuring Parkinson’s disease progression (MDS-UPDRS), will head the board.

The "UAE Automotive Spare Parts E-Commerce Market Size, Share, Growth Drivers, Trends, Opportunities, Competitive Landscape & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the "Tender Offer"), a medical research and development company specializing in regenerative medicine technologies, listed on the Tokyo Stock Exchange Growth Market.

A Los Angeles Superior Court jury today delivered a $40 million verdict against Johnson & Johnson.

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired MoonLake Immunotherapeutics ("MoonLake" or the Company") (NASDAQ: MLTX) securities between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”).

The Bay Area Robotics Association (BARA) has officially launched as a member-driven industry platform connecting corporates, roboticists, investors, and startups. BARA members will help to shape robotics and embodied AI in San Francisco, Silicon Valley, and beyond. BARA was unveiled today at the Humanoids Summit Silicon Valley, an industry event where leading minds in humanoid robotics, embodied AI and physical AI are convening from around the world. More information is available at https://www.bayarearobotics.org/.

As the leader of the No. 1 defense in the country, Ohio State University’s Caleb Downs has been named the 2025 Paycom Jim Thorpe Award Winner. The announcement was made live tonight on The Home Depot College Football Awards on ESPN. Downs received the 2025 honor – given to the top defensive back in college football based on performance on the field, athletic ability and character – on behalf of the Oklahoma Sports Hall of Fame, Jim Thorpe Association and presenting sponsor Paycom.

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) securities between February 23, 2022 and October 29, 2025, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Bitdeer Technologies Group (“Bitdeer”) (NASDAQ: BTDR) on behalf of those who purchased or otherwise acquired Bitdeer securities between June 6, 2024, and November 10, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is February 2, 2026.

Crescent Energy Finance LLC (“CE Finance”), a wholly owned subsidiary of Crescent Energy Company (NYSE: CRGY) (“Crescent”) announced today the early results of the previously announced (i) offer to exchange (the “2029 Notes Exchange Offer”) any and all 7.75% Senior Notes due 2029 (the “Existing Vital 2029 Notes”) issued by Vital Energy, Inc. (“Vital”) that are held by Eligible Holders (as defined below) for up to $298,214,000 aggregate principal amount of new 7.75% Senior Notes due 2029 issued by CE Finance (the “New Crescent 2029 Notes”), (ii) offer to exchange (the “2030 Notes Exchange Offer” and, together with the 2029 Notes Exchange Offer, the “Exchange Offers”) any and all 9.750% Senior Notes due 2030 (the “Existing Vital 2030 Notes” and, together with the Existing Vital 2029 Notes, the “Existing Vital Notes”) issued by Vital that are held by Eligible Holders for up to $302,364,000 aggregate principal amount of new 9.750% Senior Notes due 2030 issued by CE Finance (the “New Crescent 2030 Notes” and, together with the New Crescent 2029 Notes, the “New Crescent Notes”), and (iii) related solicitations of consents (each, a “Consent”) by CE Finance from Eligible Holders to adopt certain proposed amendments (the “Proposed Amendments”) to each of the indentures governing the Existing Vital Notes, which, if adopted, would eliminate substantially all of the restrictive covenants, certain events of default and certain other provisions currently contained therein (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”).

A New Mexico jury has returned a $220 million verdict, finding that the Michelin North America tire company was liable for a deadly crash that killed three members of a Texas family in the summer of 2021.

If you have suffered a loss on your DeFi Technologies (“DeFi” or the “Company”) (NASDAQ:DEFT) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

Law Offices of Howard G. Smith announces an investigation on behalf of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI) investors concerning the Company’s possible violations of federal securities laws.

WiresConnect concluded their second-ever invite-only conference, which brought together visionary designers, entrepreneurs, creatives, and industry leaders shaping the future of fashion and beauty for a day full of strategic conversation and insightful collaboration. The attendees explored timely topics such as sustainability, digital innovation, inclusivity, and the evolving relationship between style, self-expression, and technology.

General American Investors Company, Inc. (NYSE: GAM), a closed-end investment company, announced that the price at which shares of its common stock will be issued to stockholders who elected to receive additional shares in payment of the 2025 year-end dividend and distribution on its common stock will be $58.745 per share. The issue price represents the average between the high and the low prices on the New York Stock Exchange on December 12, 2025, which was below the net asset value of $65.40 per share on that date. The dividend and distribution is payable on December 26, 2025. As announced on November 5, the dividend and distribution amounts to $6.40 per share in the aggregate and is estimated to consist of:

FAIRHOLME FUNDS, INC.

Halliburton Company (NYSE: HAL) will host a conference call on Wednesday, January 21, 2026, to discuss its fourth quarter 2025 financial results. The call will begin at 8:00 a.m. CT (9:00 a.m. ET).

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI) investors concerning the Company’s possible violations of the federal securities laws.

OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced the following net asset value (“NAV”) estimate at November 30, 2025.

Granite Real Estate Investment Trust (“Granite” or the “Trust”) (TSX: GRT.UN / NYSE: GRP.U) announced today that the last day of trading for Granite’s trust units ("Units") on the New York Stock Exchange ("NYSE") is expected to be December 31, 2025.

The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral suspension, a first-in-class, single-dose oral medication for the treatment of uncomplicated urogenital gonorrhea in adults and pediatric patients 12 years and older weighing at least 35 kg. The development of NUZOLVENCE was part of a private, not-for-profit collaboration with The Global Antibiotic Research and Development Partnership (GARDP), which sponsored and led the Phase 3 clinical trial that supported FDA approval.

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the “Replacement Term Loans”) of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the “Third Amendment Term Loans”) and its outstanding term B loans due 2028 (the “First Incremental Term Loans”). The applicable margin is anticipated to be (i) 3.75% per annum for Replacement Term Loans with an interest rate determined by reference to term SOFR and (ii) 2.75% per annum for Replacement Term Loans with an interest rate determined by reference to the alternate base rate; the margin applicable to the Replacement Term Loans represents a 0.50% per annum reduction for the Third Amendment Term Loans and a 0.25% per annum reduction for the First Incremental Term Loans. The Replacement Term Loans will mature on January 15, 2031, which is same maturity date as the Third Amendment Term Loans and which represents a maturity extension of the First Incremental Term Loans from September 29, 2028.

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and September 2025, having exercise prices of $36.00 and $10.98 per share, respectively, at a reduced exercise price of $7.05 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-1 (No. 333-284277) and Form S-3 (No. 333-290580). The gross proceeds to the Company from the exercise of the warrants were approximately $3.1 million, prior to deducting placement agent fees and estimated offering expenses.

The "Disulfiram Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.

The "Instant Hot Pot Self-Heating Rice Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Fermi Inc. (“Fermi” or “the Company”) (NASDAQ: FRMI) for violations of the securities laws.

KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Preserve and Retreat, two new communities within the highly desirable Crosswinds master plan in Morgan Hill, California. Nestled between the Santa Cruz Mountains and Silicon Valley, Morgan Hill blends small-town charm and scenic views with a welcoming downtown district where residents can enjoy an array of boutique shopping, acclaimed wineries and top-rated dining. The new homes are designed for the way people live today, with popular features like modern kitchens overlooking large great rooms, expansive bedroom suites with walk-in closets, and ample storage space. The two-story, single-family floor plans at Preserve at Crosswinds range from 2,018 to 2,111 square feet and offer up to five bedrooms and three baths, while the two-story duet homes at Retreat at Crosswinds range from 2,345 to 2,529 square feet and feature up to five bedrooms and four baths. Homeowners will appreciate the planned community amenities, which include a pool, park, children’s playground and clubhouse with a lounge and barbecue area. Crosswinds is also walking distance to local schools and parks.

Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below.

LS Cable & System Ltd. (“LS C&S”), a global leader in power and communication cable and system solutions, today announced plans for a significant additional investment in Chesapeake, Virginia. Undertaken through three LS C&S subsidiaries, the project is expected to be the single largest capital investment in the history of the Hampton Roads region.

AM Best has downgraded the Financial Strength Rating (FSR) to C++ (Marginal) from B- (Fair) and the Long-Term Issuer Credit Rating (Long-Term ICR) to “b+” (Marginal) from “bb-” (Fair) of Southern General Insurance Company (SGIC) (Atlanta, GA). The outlook of the FSR has been revised to stable from negative, while the outlook of the Long-Term ICR is negative. Concurrently, AM Best has withdrawn the Credit Ratings (ratings) as the company has requested to no longer participate in AM Best’s interactive rating process.

Crescent Energy Company (NYSE: CRGY) (“Crescent” or the “Company”), today announced it received overwhelming stockholder approval for the issuance of Crescent Class A common stock in connection with its proposed merger (the “Merger”) with Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy”) at a special meeting of stockholders held today. The Merger is expected to close on December 15, 2025.